347 results on '"Brown, J.R."'
Search Results
2. Characterizing the molecular epidemiology of anaesthesia work area transmission of Staphylococcus aureus sequence type 5
3. Transmission of Staphylococcus aureus in the anaesthesia work area has greater risk of association with development of surgical site infection when resistant to the prophylactic antibiotic administered for surgery
4. Operation of scintillators and SiPMs at high temperatures and their application for borehole logging
5. Characterizing the molecular epidemiology of anaesthesia work area transmission of Staphylococcus aureus sequence type 5
6. Sanborn Field: Effect of 100 Years of Cropping on Soil Parameters Influencing Productivity
7. Effects of Long-Term Cropping on Organic Matter Content of Soils: Implications for Soil Quality*
8. How resilient are US rangeland ecosystems?
9. Genomic investigations of unexplained acute hepatitis in children
10. Severing Corneal Nerves in One Eye Induces Sympathetic Loss of Immune Privilege and Promotes Rejection of Future Corneal Allografts Placed in Either Eye
11. Optimisation of Bio-Oil Extraction Process from Beauty Leaf (Calophyllum Inophyllum) Oil Seed as a Second Generation Biodiesel Source
12. SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib versus Bendamustine + Rituximab (BR) in Patients with Treatment-Naive (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).
13. SEQUOIA : Results of a Phase 3 Randomised Study of Zanubrutinib versus Bendamustine + Rituximab in Patients with Treatment-Naive Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma.
14. Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial.
15. XPS depth profiling study on the passive oxide film of carbon steel in saturated calcium hydroxide solution and the effect of chloride on the film properties
16. P.70 Stay home: the effect of COVID-19 on post-operative length of stay in obstetric patients
17. Recommendations for the introduction of metagenomic next-generation sequencing in clinical virology, part II
18. 842P Secreted factors determine resistance to idelalisib in splenic marginal zone lymphoma (MZL) models
19. Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure
20. Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure
21. Zanubrutinib monotherapy for patients with treatment naive chronic lymphocytic leukemia and 17p deletion.
22. Historicism and cross-culture comparison
23. Recent results in fragmentation isomer spectroscopy with rising
24. Experimental identification of the T = 1, Jπ = 6+ state of 54Co and isospin symmetry in A = 54 studied via one-nucleon knockout reactions
25. Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma
26. In situ transmission Fourier transform infrared (FT-IR) spectroscopy investigations of the surface chemistry of gettering common gases in vacuum systems with a common commercial flashed getter alloy as a function of temperature
27. A direct measurement of the 17O(α,γ)21Ne reaction in inverse kinematics and its impact on heavy element production
28. Soil change, soil survey, and natural resources decision making: a blueprint for action
29. Climate change and biotic invasions: a case history of a tropical woody vine
30. An integrated framework for science-based arid land management
31. Role of Sex in Determining Treatment Type for Patients Undergoing Endovascular Lower Extremity Revascularization
32. A light scattering theory applicable to ions which aggregate in solution and possess two charge centers of one sign and one charge center of the opposite sign: aggregation of BTA-243 in an aqueous medium
33. Enhanced biotransformation of TCE using plant terpenoids in contaminated groundwater
34. Micro-patch and community scale spatial distribution of herbaceous cover in a grazed eucalypt woodland
35. A direct measurement of the O( , ) Ne reaction in inverse kinematics and its impact on heavy element production
36. A direct measurement of the ¹⁷O(α,γ)²¹Ne reaction in inverse kinematics and its impact on heavy element production
37. MCL-1 and PKA/AMPK Axis Fuel Venetoclax Resistance in Lymphoid Cancers
38. Thermocapillary effects on the stability of a heated, curved meniscus
39. Evolutionary relationships of bacterial and archaeal glutamine synthetase genes
40. Remodelling general practice training: Tension and innovation
41. A two-stage traveling salesman procedure for the single machine sequence-dependent scheduling problem
42. Feeding wash water solids to sows during gestation and lactation: sow productivity, pig performance, and tissue compositions
43. Mitochondrial DNA length variation and heteroplasmy in populations of white sturgeon (Acipenser transmontanus)
44. S868 EMERGING CLINICAL ACTIVITY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY (AB), IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
45. INITIAL RESULTS OF A MULTICENTER PHASE 2 STUDY OF VENETOCLAX IN COMBINATION WITH DOSE-ADJUSTED R-EPOCH FOR PATIENTS WITH RICHTER'S SYNDROME (CRC-043)
46. IDELALISIB PLUS ANTI-CD20 USED SECOND LINE SHOWS IMPROVED PFS AND COMPARABLE SAFETY COMPARED TO LATER LINE THERAPY OF RELAPSED CLL
47. PF374 IBRUTINIB PLUS FLUDARABINE, CYCLOPHOSPHAMIDE, AND RITUXIMAB (IFCR) AS INITIAL THERAPY FOR YOUNGER PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE-ARM, MULTICENTER, PHASE 2 TRIAL
48. CLINICAL ACTIVITY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY (AB) IN PATIENTS (PTS) WITH (W/) RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
49. PS1132 INHERITED DNA REPAIR AND CELL CYCLE GENE DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
50. PS1148 PRELIMINARY RESULTS OF A PHASE 1B/2 DOSE‐ESCALATION AND COHORT‐EXPANSION STUDY OF THE NONCOVALENT, REVERSIBLE BRUTON'S TYROSINE KINASE INHIBITOR (BTKI), VECABRUTINIB, IN B‐CELL MALIGNANCIES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.